Holen Sie sich die Stockscreener-App
65.34
0.91%
0.59
Handel nachbörslich:
65.23
-0.11
-0.17%
Schlusskurs vom Vortag:
$64.75
Offen:
$66.15
24-Stunden-Volumen:
1.22M
Relative Volume:
0.93
Marktkapitalisierung:
$5.06B
Einnahmen:
$646.34M
Nettoeinkommen (Verlust:
$-512.40M
KGV:
-9.7711
EPS:
-6.6871
Netto-Cashflow:
$202.76M
1W Leistung:
+2.70%
1M Leistung:
+18.33%
6M Leistung:
+31.47%
1J Leistung:
+86.58%
1-Tages-Spanne:
$63.46
$66.90
1-Wochen-Bereich:
$61.50
$66.90
52-Wochen-Spanne:
$30.08
$66.90
Hinge Health Inc Stock (HNGE) Company Profile
Firmenname
Hinge Health Inc
Sektor
Branche
Telefon
415-689-8429
Adresse
455 MARKET STREET, SAN FRANCISCO
Compare HNGE vs VEEV, BTSG, TEM, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HNGE
Hinge Health Inc
|
65.34 | 5.01B | 646.34M | -512.40M | 202.76M | -6.6871 |
VEEV
Veeva Systems Inc
|
159.54 | 26.24B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
63.23 | 12.38B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
47.82 | 8.90B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.34 | 7.44B | 1.34B | 230.70M | 440.96M | 2.6695 |
Hinge Health Inc Stock (HNGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Wells Fargo | Overweight |
| 2025-09-05 | Eingeleitet | Robert W. Baird | Neutral |
| 2025-07-14 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-06-16 | Eingeleitet | Barclays | Overweight |
| 2025-06-16 | Eingeleitet | BofA Securities | Buy |
| 2025-06-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-06-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-06-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2025-06-16 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-06-16 | Eingeleitet | Needham | Buy |
| 2025-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2025-06-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-06-16 | Eingeleitet | Raymond James | Outperform |
| 2025-06-16 | Eingeleitet | Stifel | Buy |
| 2025-06-16 | Eingeleitet | Truist | Buy |
| 2025-06-16 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - Yahoo Finance
Bessemer funds tied to Hinge Health (NASDAQ: HNGE) report June share sales - Stock Titan
Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares? - The Motley Fool
KeyBanc raises Hinge Health stock price target on surgery expansion - Investing.com
Citizens maintains Hinge Health stock rating on customer conference By Investing.com - Investing.com Canada
Citizens maintains Hinge Health stock rating on customer conference - Investing.com
Hinge Health stock hits all-time high at 66.6 USD By Investing.com - Investing.com Australia
Hinge Health stock hits all-time high at 66.6 USD - Investing.com India
RBC Capital Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $75 - Moomoo
HNGE Maintained by RBC Capital -- Price Target Raised to $75.00 - GuruFocus
HNGE Maintained by Truist Securities -- Price Target Raised to $85 - GuruFocus
Hinge Health's New Products, Margin Gains Support Growth Outlook, RBC Says - Moomoo
Truist raises Hinge Health stock price target on growth outlook By Investing.com - Investing.com Australia
HNGE Maintained by Barclays -- Price Target Raised to $70 - GuruFocus
Hinge Health (NYSE:HNGE) Price Target Raised to $85.00 at Truist Financial - MarketBeat
Truist raises Hinge Health stock price target on growth outlook - Investing.com
Hinge Health Expands HingeSelect to Offer End-to-End MSK Surgical Care - Zacks Investment Research
Truist Raises Price Target on Hinge Health to $85 From $79, Keeps Buy Rating - Moomoo
HNGE Maintains Buy Rating -- Price Target Raised to $76.00 by Ne - GuruFocus
Hinge Health raises Q2 and FY 2026 guidance; projects above estimate - MSN
Needham raises Hinge Health stock price target on guidance boost By Investing.com - Investing.com Australia
Needham & Company LLC Increases Hinge Health (NYSE:HNGE) Price Target to $76.00 - MarketBeat
Stifel reiterates Hinge Health stock rating on surgical expansion By Investing.com - Investing.com Australia
Stifel reiterates Hinge Health stock rating on surgical expansion - Investing.com
RBC Raises Price Target on Hinge Health to $75 From $65, Keeps Outperform Rating - marketscreener.com
Needham raises Hinge Health stock price target on guidance boost - Investing.com
RBC Capital raises Hinge Health stock price target on guidance boost - Investing.com
Hinge Health Inc (HNGE) PT Raised to $76 at Needham - StreetInsider
Hinge Health Inc (HNGE) PT Raised to $75 at RBC Capital - StreetInsider
HNGE: Unified care platform, AI-driven growth, and new products fuel strong financial outperformance - TradingView
Hinge Health adds surgery to HingeSelect, delivering a fully integrated musculoskeletal care platform - 01net
Piper Sandler reiterates Hinge Health stock rating at Overweight - Investing.com
Piper Sandler reiterates Hinge Health stock rating at Overweight By Investing.com - Investing.com Canada
Hinge Health (HNGE) Increases 2026 Revenue Guidance Due to Stron - GuruFocus
HNGE: 2026 revenue guidance raised to $818–$824 million, reflecting 40% year-over-year growth - TradingView
Stifel raises Hinge Health stock price target on revenue guidance By Investing.com - Investing.com South Africa
Stifel raises Hinge Health stock price target on revenue guidance - Investing.com
Hinge Health raises 2026 revenue guidance, cites strong momentum - Investing.com UK
Hinge Health raises 2026 revenue guidance ahead of inaugural investor day - StreetInsider
Hinge Health stock rises after raising 2026 revenue guidance By Investing.com - Investing.com Canada
Hinge Health raises 2026 revenue guidance, cites strong momentum By Investing.com - Investing.com South Africa
Hinge Health raises FY26 revenue to $824M, hosts Investor Day - scanx.trade
Hinge Health (NYSE: HNGE) lifts 2026 outlook with 40% revenue growth - Stock Titan
Hinge Health hosts its first Investor Day and raises guidance - The Joplin Globe
ING Groep NV Buys Shares of 141,000 Hinge Health Inc. $HNGE - MarketBeat
Stifel Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $67 - Moomoo
Atomico group owns 2.88% of Hinge Health (HNGE) after 13G/A amendment - Stock Titan
Truist Financial Maintains Hinge Health(HNGE.US) With Buy Rating - Moomoo
Hinge Health Claims Data And Migraine Device Expand Digital Care Story - Yahoo Finance
Hinge Health (NYSE:HNGE) Hits New 1-Year HighHere's Why - MarketBeat
Citizens raises Hinge Health stock price target on strong Q1 results - Investing.com
Finanzdaten der Hinge Health Inc-Aktie (HNGE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.06%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):